Patents by Inventor Nicholas R. Lemoine

Nicholas R. Lemoine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of PI3K p-delta 110 for use in delivery of viruses in the treatment of cancer
    Patent number: 11351209
    Abstract: The present invention provides a composition comprising a phosphatidylinositol 3-kinase (PI3K) inhibitor and a modified virus for separate, subsequent or simultaneous use in the treatment of cancer, wherein the modified virus is for intravenous administration.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: June 7, 2022
    Assignee: Queen Mary University of London
    Inventors: Yaohe Wang, Mark Ferguson, Nicholas R. Lemoine
  • Inhibitors Of PI3K P-Delta 110 For Use In Delivery Of Viruses In The Treatment Of Cancer
    Publication number: 20190022156
    Abstract: The present invention provides a composition comprising a phosphatidylinositol 3-kinase (PI3K) inhibitor and a modified virus for separate, subsequent or simultaneous use in the treatment of cancer, wherein the modified virus is for intravenous administration.
    Type: Application
    Filed: January 11, 2017
    Publication date: January 24, 2019
    Inventors: Yaohe Wang, Mark Ferguson, Nicholas R. Lemoine